This research investigates the role of central histaminergic transmission in modulating behaviors associated with nicotine withdrawal. It suggests that blocking histamine H1 or H2 receptors could help mitigate withdrawal symptoms such as anxiety and physical discomfort.
Understanding these mechanisms may contribute to developing new strategies to support individuals quitting smoking, ultimately improving public health outcomes.